Studies have shown that changes in CCK expression or a reduction in a > number of CCK receptors contributes to various gastrointestinal and metabolic diseases such as diabetes mellitus, gall stone disease and irritable bowel syndrome (Chandra and Liddle 2007). The gene discussed is CCK; the disease is metabolic disease.